Search

Astellas Pharma Inc.
  • Top MenuAbout
    About EST-C
    Astellas Established Markets-Commercial (EST-C) is a regional centre of excellence in healthcare supporting teams across Europe, Australia and Canada
    Read More
    • President’s Message
    • Philosophy
    • Vision & Strategy
    • Group Code of Conduct
      • Social Media Code of Conduct
    • About Established Markets Commercial (EST-C)
    • Policies & Position Statements
    • Patient Organisation Support Grid
    • Member of the Public, Patients and Journalists Disclosure
    • Transparency
    • Support for Medical Education
  • Top MenuTherapy Areas
    Transplantation
    Transplantation refers to the transplantation Of organic material. If the organs such as the kidneys of the liver permanently ...
    Read More
    • Transplantation
    • Urology
    • Oncology
      • Our Commitment to Patients
      • Our Science
      • Our People
    • Nephrology
      • Our Commitment to the Patient Community
      • Our Science
      • Our People
  • Top MenuInnovation
    Clinical Trials
    Astellas has established a website to disclose information obtained from Astellas-sponsored clinical trials…
    Read More
    • R & D
      • Clinical Trials
      • Approach
      • Ethics & Principles
  • Top MenuSustainability
  • Top MenuMedia Centre
    Latest News
    The Astellas EST-C Communications team will respond to emails from journalists. For general media enquiries, please email [email protected].
    Read More
    • Latest News
    • Media Resources
    • Astellas at ERA 2022

Common header menu

  • COVID-19
  • Patient Focus
    • Patient Partnerships
      • The Patient Partnerships Team
      • Working with the Patient Community
      • Your Experience Matters
  • CAREERS
    • Astellas Pharma Europe Limited Recruitment Privacy Notice
  • CONTACT US
  • WORLDWIDE
  1. Home
  2. Media Centre
  3. Latest News

Latest News

  • Latest
  • Keyword
  • Date
Search
  • 2023
  • 2022
  • 2021
  • Latest
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
ajax-loading-img
Error

Jan, 2023

Global
News / Stories
Jan 05, 2023
Let's Talk Prostate Cancer
lets_talk_prostate_cancer

Expert Group calls for urgent implementation of new European Union (EU) guidance on risk-based prostate cancer screening across EU member states

The Let’s Talk Prostate Cancer...

Read More

Jun, 2022

Global
News / Stories
Jun 30, 2022
Claus Zieler elected to board of EFPIA
Claus Zieler

Claus Zieler, President, Astellas Established Markets, has been appointed to the board of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the main...

Read More

Nov, 2021

Global
News / Stories
Nov 24, 2021
World's First Use of Environmentally Friendly Biomass-based Plastic for Blister Packages

TOKYO, October 11, 2021 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) begin using biomass-based plastics made from plant-derived materials in...

Read More
Nothing Found

Unfortunately, we weren't able to find a match for you.

Nothing Found

Unfortunately, we weren't able to find a match for you.

 

MAT-GB-NON-2023-00071 August 2023

 

The Astellas EST-C Communications team
will respond to emails from journalists.
For general media enquiries,
please email [email protected].

LogoSolgan

Follow us on social media

linkedin_icon twitter_icon

Bottom footer menu

  • SITE MAP
  • PRIVACY NOTICE
  • TERMS OF USE
  • CONTACT US
  • COOKIES POLICY
  • MODERN SLAVERY ACT
  • PROCUREMENT
© 2022-2023 Astellas Pharma Inc. or its affiliates.

Update Cookies Preferences